Analysis of the short form-36 (SF-36): The beta-binomial distribution approach

Statistics in Medicine

Volumn 26, Issue 6, 2007, Pages 1318-1342

  Arostegui, Inmaculada ^a   Núñez Antón, Vicente ^a   Quintana, José M ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE GALDAKAO   (Spain)

Author keywords

Beta binomial model; Goodness of fit; Health related quality of life; SF 36

Indexed keywords

ADULT; ANOREXIA NERVOSA; ANXIETY; ARTICLE; BINGE EATING DISORDER; BINOMIAL DISTRIBUTION; BODY MASS; BULIMIA; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; DISEASE SEVERITY; EATING DISORDER; EMOTIONALITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATHEMATICAL COMPUTING; MENTAL HEALTH; MULTIPLE LINEAR REGRESSION ANALYSIS; NORMAL DISTRIBUTION; PAIN; PREDICTION; QUALITY OF LIFE; SHORT FORM 36; SIMULATION; SOCIAL INTERACTION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BINOMIAL DISTRIBUTION; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; SPAIN;

EID: 33847702106     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2612     Document Type: Article

References (54)

1. Testa MA, Simonson DC. Assessment of quality of life outcomes. New England Journal of Medicine 1996; 334:835-840.
2. Goldsmith SB. The status of health status indicators. Health Services Report 1972; 87:212-220.
3. Goldsmith SB. A reevaluation of health status indicators. Health Services Report 1973; 88:937-941.
4. Katz S. The science of quality of life. Journal of Chronic Diseases 1987; 40:459-465.
5. Spitzer WO. State of science 1986: quality of life and functional status as target variables for research. Journal of Chronic Diseases 1987; 40:465-471.
6. Ware JE, Snow KK, Kosinski MA, Gandek B. SF-36 Health Survey, Manual and Interpretation Guides. The Health Institute, New England Medical Center: Boston, 1993.
7. Alonso J, Prieto L, Antó JM. La versión española del SF-36 health survey (Cuestionario de salud SF-36): un instrumento para la medida de los resultados clínicos. Medicina Clinica (Barcelona) 1995; 104:771-776.
8. Schumacher M, Olschewski M, Schulgen G. Assessment of quality of life in clinical trials. Statistics in Medicine 1991; 10:1915-1930.
9. Fairclough D. Design and Analysis of Quality of Life Studies in Clinical Trials. Chapman & Hall: London, 2002.
10. Olschewski M, Schumacher M. Statistical analysis of quality of life data in cancer clinical trials. Statistics in Medicine 1990; 9:749-763.
11. Cox DR, Fitzpatrick R, Fletcher AE, Gore SM, Spiegelhalter DJ, Jones DR. Quality-of-life assessment: can we make it simple? Journal of the Royal Statistical Society, Series A - General 1992; 155:353-375. (Disc: 375-393).
12. Fayers PM, Machin D. Quality of Life. Assessment, Analysis and Interpretation. Wiley: London, 2000.
13. Mesbah MF, Cole B, Ting Lee M. Statistical Methods for Quality of Life Studies. Design, Measurements and Analysis. Kluwer Academic Publishers: Boston, 2002.
14. Torrance GW. Utility approach to measuring health-related quality-of-life. Journal of Chronic Diseases 1987; 40:593-600.
15. Lall R, Campbell MJ, Walters SJ, Morgan K, MRC CFAS. A review of ordinal regression models applied on health-related quality of life assessments. Statistical Methods in Medical Research 2002; 11:49-67.
16. Walters SJ, Campbell MJ, Lall R. Design and analysis of trials with quality of life as an outcome: a practical guide. Journal of Biopharmaceutical Statistics 2001; 11:155-176.
17. Van Hoeken D, Lucas AR, Hoek HW. Epidemiology. In Neurobiology in the Treatment of Eating Disorders, Hoek HW, Treasure JL, Katzman MA (eds). Wiley: London, 1998; 97-126.
18. Padierna A, Quintana JM, Arostegui I, González N, Horcajo MJ. The health-related quality of life in eating disorders. Quality of Life Research 2000; 9:667-674.
19. Padierna A, Quintana JM, Arostegui I, González N, Horcajo MJ. Changes in health-related quality of life among patients treated for eating disorders. Quality of Life Research 2002; 11:545-552.
20. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care 1992; 30:473-483.
21. Stansfeld SA, Roberts R, Foot SP. Assessing the validity of the SF-36 general health survey. Quality of Life Research 1997; 6:217-224.
22. Brazier JE, Harper R, Jones NMB, O'Cathain A, Thomas KJ, Usherwood T, Westlake L. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. British Medical Journal 1992; 305:160-164.
23. Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the quality of well being scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. Journal of Clinical Epidemiology 1998; 51:755-762.
24. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: measurement by the medical outcomes study instrument. Annals of Internal Medicine 1992; 116:129-137.
25. Dawson J, Fitzpatrick R, Carr A, Murray D. Questionnaire on the perceptions of patients about total hip replacement. Journal of Bone and Joint Surgery-American Volume 1996; 78-B:185-190.
26. Harper R, Brazier JE, Waterhouse JC, Walters SJ, Jones NMB, Howard P. Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting. Thorax 1997; 52:879-887.
27. Rose MS, Koshman ML, Spreng S, Sheldom R. Statistical issues encountered in the comparison of health related quality of life in disease patients to published general population norms: problems and solutions. Journal of Clinical Epidemiology 1999; 52:405-412.
28. Walters SJ, Campbell MJ. The use of bootstrap methods for analyzing health related quality of life outcomes (particularly the SF-36). Health and Quality of Life Outcomes 2004; 2:70. DOI: 10.1186/1477-7525-2-70.
29. Cheung Y-B, Thumboo J, Machin D, Feng P-H, Boey M-L, Thio S-T, Fong K-Y. Modelling variability of quality of life scores: a study of questionnaire version and bilingualism. Quality of Life Research 2004; 13:897-906.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association: Washington, DC, 1994.
31. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983; 67:361-370.
32. Garner DM, Garfinkel PE. Eating attitudes test: an index of the symptoms of anorexia nervosa. Psychological Medicine 1979; 9:273-279.
33. SAS Institute Inc. SAS Procedures Guide, Version 6. SAS Institute, Cary, NC, 1994.
34. MathSoft, Inc. S-PLUS 2000 User's Guide. MathSoft, Data Analysis Products Division, Seattle, WA, 1999.
35. Skellam JG. A probability distribution function derived from the binomial distribution by regarding the probability of success as variable between the sets of trials. Journal of the Royal Statistical Society, Series B 1948; 10:257-261.
36. Chatfield C, Goodhart GJ. The beta-binomial model for consumer purchasing behaviour. Applied Statistics 1970; 19:240-250.
37. Weil CS. Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis and carcinogenesis. Food and Cosmetics Toxicology 1970; 8:177-182.
38. Griffiths DAB. Maximum likelihood estimation for the beta-binomial distribution and an application to the household distribution of the total number of cases of a disease. Biometrics 1973; 29:637-648.
39. Williams DA. The analysis of binary responses from toxicological experiments involving reproduction and teratogenicity. Biometrics 1975; 31:949-952.
40. Crowder MJ. Beta-binomial ANOVA for proportions. Applied Statistics 1978; 27:34-37.
41. Williams DA. Extra-binomial variation in logistic linear models. Applied Statistics 1982; 31:144-148.
42. Morgan BJT. Analysis of Quantal Response Data. Chapman & Hall: London, 1992.
43. Cytel Software Corporation. EGRET for Windows. User Manual. Cytel Software Corporation, Cambridge, MA, 1999.
44. Walters SJ, Campbell MJ. The use of bootstrap methods for estimating sample size and analyzing health related quality of life outcomes. Statistics in Medicine 2005; 24:1075-1102. DOI: 10.1002/sim.1984.
45. Kendall PC. Clinical significance. Journal of Consulting and Clinical Psychology 1999; 67:283-284.
46. Clancy C, Eisenberg J. Outcomes research care: measuring the end results of health care. Science 1998; 282:245-246.
47. Wyrwich K, Wollinsky F. Identifying meaningful intra-individual change standards for health-related quality of life measures. Journal of Evaluation in Clinical Practice 2000; 6:39-49.
48. Ferguson RJ, Robinson AB, Splaine M. Use of the reliable change index to evaluate clinical significance in SF-36 outcomes. Quality of Life Research 2002; 11:509-516.
49. White IR, Thompson SG. Choice of test comparing two groups, with particular application to skewed outcomes. Statistics in Medicine 2003; 22:1205-1215. DOI: 10.1002/sim.1420.
50. Heeren T, D'Agostino RB. Robustness of the two independent samples t-test when applied to ordinal scaled data. Statistics in Medicine 1987; 6:79-90.
51. Sullivan LM, D'Agostino RB. Robustness and power of analysis of covariance applied to data distorted from normality by floor effects: homogeneous regression slopes. Statistics in Medicine 1996; 15:477-496.
52. Sullivan LM, D'Agostino RB. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials. Statistics in Medicine 2003; 22:1317-1334. DOI: 10.1002/sim.1433.
53. Ware JE, Kosinski M, Dewey JE. How to Score Version 2.0 of the SF-36 Health Survey. Quality Metric Incorporated, Lincoln, RI, 2000.
54. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, Santed R, Valderas JM, Ribera A, Domingo-Salvany A, Alonso J. El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gaceta Sanitaria 2005; 19:135-150.